In this fact-filled session we will hear from “both sides of the house” – first from an innovative information technology leader and then a senior scientist who uses the solutions provided by IT. Kate Hardy of MOMA was tasked with finding the right solution to meet scientists’ need for insight into sequence activity relationships. She will explain the requirements she faced and her decision making process  Then, Arman Aksoy, a senior computational biologist,  will speak to how the new solution is meeting the needs of scientific teams who are working on developing the next generation of precision medicines by targeting the molecular machines that underlie human disease. To conclude, PerkinElmer’s Dr. David Gosalvez will expand on how MOMA Therapeutics’ biotech solution is applicable to the needs of other biotechnology startups.

Featured Speakers

Kate Hardy

Director of Informatics and Technology
MOMA Therapeutics

Having spent five years in life science software delivery and services leadership roles, Kate understands the varied needs of biotech companies and has learned a thing or two about how high quality data and user-friendly technology enable research discoveries and business intelligence. User success has always been central to her methodology and she is passionate about driving engagement across all levels of an organization, from bench researchers to business leadership.

After consulting with Third Rock Ventures portfolio companies for a year and helping launch companies with integrated and highly adoptable informatics platforms, Kate accepted a full time role at the Boston-based biotech startup MOMA Therapeutics. Her goal is to be a trusted advisor to both the business and the research sides of the company while deploying and supporting innovative technology solutions that are just as cutting-edge as MOMA’s ambitious research goals.

Arman Aksoy, Ph.D.

Senior Scientist
MOMA Therapeutics

Arman Aksoy received his BSc in Molecular Biology and Genetics at Boğaziçi University with a double-major in Mathematics. He completed his Ph.D. in Computational Biology in the Tri-Institutional Training Program at Memorial Sloan Kettering Cancer Center where he was part of major cancer genomics efforts such as The Cancer Genome Atlas and Cancer Target Discovery and Development. He did his post-doctoral fellowship at Hammer Lab of Icahn School of Medicine, Genetics and Genomics Department, Mount Sinai Hospital, where he focused on biomarker discovery for immunotherapies. Arman then continued his Immunology research at Hammer Lab at the Medical University of South Carolina as a Research Assistant Professor. Arman joined MOMA Therapeutics in 2020 as a senior computational scientist implementing data-driven approaches to better understand molecular machines and help the team with target discovery efforts.


David Gosalvez, Ph.D.

Director, Science and Technology
PerkinElmer, Inc.

Dr. Gosalvez leads an interdisciplinary team of domain experts in software and database architecture at PerkinElmer Informatics. His team is chartered with creating novel scientific data management solutions. Dr. Gosalvez received his undergraduate degree from UC Berkley and his Ph.D. in chemistry from the Massachusetts Institute of Technology.

NOW AVAILABLE ON-DEMAND